Show simple item record

Sirolimus as a new drug for treatment of RIF patients with elevated Th17/Treg Ratio: a randomized, double-blind, phase II clinical trial

dc.contributor.authorAhmadi, M
dc.contributor.authorDanaii, S
dc.contributor.authorBerjis, K
dc.contributor.authorNouri, M
dc.contributor.authorYousefi, M
dc.date.accessioned2018-08-26T06:35:17Z
dc.date.available2018-08-26T06:35:17Z
dc.date.issued2018
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/44173
dc.language.isoEnglish
dc.relation.ispartofHUMAN REPRODUCTION
dc.relation.ispartof34th Annual Meeting of the European-Society-of-Human-Reproduction-and-Embryology (ESHRE)
dc.titleSirolimus as a new drug for treatment of RIF patients with elevated Th17/Treg Ratio: a randomized, double-blind, phase II clinical trial
dc.typeMeeting Abstract
dc.citation.volume33
dc.citation.spage138
dc.citation.epage138
dc.citation.indexWeb of science


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record